UCL

24/7 Market News Publishes Report on Public Club Ownership Models Including Brera Holdings for UCL Championship Weekend

Retrieved on: 
fredag, maj 31, 2024
UCL, Real Madrid CF, News, UEFA, Real, Editorial, MCO, Wembley Stadium, Corporate development, Football, Brera, Sport

Denver, Colorado--(Newsfile Corp. - May 31, 2024) - 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report highlighting several public ownership models of European Professional Football (soccer) clubs, featuring Brera Holdings PLC (NASDAQ: BREA), a company democratizing Multi Club Ownership ("MCO").

Key Points: 
  • Denver, Colorado--(Newsfile Corp. - May 31, 2024) - 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, today publishes a news report highlighting several public ownership models of European Professional Football (soccer) clubs, featuring Brera Holdings PLC (NASDAQ: BREA), a company democratizing Multi Club Ownership ("MCO").
  • Borussia Dortmund takes on Real Madrid- UCL Final Saturday June 1, 2024
    To view an enhanced version of this graphic, please visit:
    Additionally, the report discusses how the UEFA Champions League (UCL), which culminates this weekend with Borussia Dortmund facing Real Madrid at London's Wembley Stadium for the 2024 UCL title, affects the various football transfer markets in Europe and beyond.
  • To read the full article on 247marketnews.com, please click here
    Aside from the UCL Finals, Brera Holdings (NASDAQ: BREA), which added Maria Xing, its new Head of Investments and Corporate Development , in a move that should contribute to Brera's efforts to add a professional Italian professional football (soccer) club.
  • Brera's endeavor is receiving further European media coverage and will be the focus of an upcoming editorial.

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Retrieved on: 
fredag, maj 17, 2024
Conference call, UCL, Cardinal Health, Marketing, European Medicines Agency, CD19, FDA, EHA, Multiple myeloma, GD2, Immunotherapy, Research, Flow cytometry, Information technology, University College London, Cardinal, SLE, Conference, BioNTech, MIA, ACS Chemical Biology, MAA, ASH, Clinical trial, Bone marrow, Trial of the century, Nucleus, ADS, ASCO, SME, Minocycline, Marketing Authorisation Application, BCMA, Society, European Hematology Association, Canadian Aviation Regulations, Patient, Nature Communications, T cell, Quarter, Therapy, Engineering, Autoimmune disease, PDUFA, ALL, EMA, TRBC, Abstract, BLA, GMP

Two patients have been enrolled and Autolus continues to expect initial clinical data in late 2024.

Key Points: 
  • Two patients have been enrolled and Autolus continues to expect initial clinical data in late 2024.
  • Enrollment of the initial cohorts are complete and further updates from the MCARTY study are anticipated in H2 2024.
  • In April 2024, Autolus announced the appointment of Mike Bonney as Chairman of the Board, and Ravi Rao M.D., as Non-Executive Director.
  • Financial Results for the Quarter Ended March 31, 2024

UCLOUDLINK GROUP INC. Announces Unaudited First Quarter 2024 Financial Results

Retrieved on: 
onsdag, maj 15, 2024
UCL, Viva Technology, Investment, Growth, Travel, Marketing, Software as a service, ADS, Internet of things, Depreciation, GAAP, SIM, Research, Human, ESIM, Platform as a service, OTA

HONG KONG, May 15, 2024 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months ended March 31, 2024.

Key Points: 
  • HONG KONG, May 15, 2024 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months ended March 31, 2024.
  • As a proportion of daily active terminals, 57.9% were from uCloudlink 1.0 international data connectivity services and 42.1% were from uCloudlink 2.0 local data connectivity services during the first quarter of 2024.
  • The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure.
  • UCLOUDLINK will hold a conference call at 8:30 a.m. Eastern Time on Wednesday, May 15, 2024 (8:30 p.m. Beijing Time on the same day) to discuss financial results and answer questions from investors and analysts.

Chegg Strengthens its Academic Advisory Board in UK and Australia, Launches New Student Advisory Council

Retrieved on: 
onsdag, maj 15, 2024
Education, Technology, Software, Artificial Intelligence, Continuing, University, Training, Aston, Knowledge, Southern New Hampshire University, State university system, Learning, UCL, Chair, Imperial College London, Faculty, Aston University, Suffolk University, Heart, Stanford University, Dean (education), Digital, Staffordshire University, Mental health, Hunter College, Senior, University of Nevada, Reno, Educational technology, Engagement, Postgraduate education, Human, Research, Interim, Williams College, Student, Public policy, School, Harvard Kennedy School, Computing, CHGG, Student Advisory Council, Multimedia

Chegg, Inc. (NYSE: CHGG) today announced the newest members of its Academic Advisory Board, strengthening its presence in the UK and Australia, and further reinforcing its commitment to student learning success and academic integrity.

Key Points: 
  • Chegg, Inc. (NYSE: CHGG) today announced the newest members of its Academic Advisory Board, strengthening its presence in the UK and Australia, and further reinforcing its commitment to student learning success and academic integrity.
  • To ensure the student voice is strongly represented alongside that of leading academics, Chegg also launched a new Student Advisory Council.
  • View the full release here: https://www.businesswire.com/news/home/20240515852954/en/
    The newest members of the Academic Advisory Board are:
    Professor Emeritus Martin Betts, who has more than 40 years’ experience in academic and senior leadership roles in Australia and the UK.
  • Together, with the founding members of the Academic Advisory Board, launched in October 2021, this group of experts provide feedback on Chegg’s product offerings and strategies.

UCLOUDLINK GROUP INC. to Report First Quarter 2024 Financial Results on May 15, 2024

Retrieved on: 
onsdag, maj 8, 2024
UCL

HONG KONG, May 08, 2024 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024 before U.S. markets open on Wednesday, May 15, 2024.

Key Points: 
  • HONG KONG, May 08, 2024 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2024 before U.S. markets open on Wednesday, May 15, 2024.
  • Management will hold a conference call to discuss these results at 8:30 a.m. U.S. Eastern Time / 8:30 p.m. Beijing Time the same day.
  • Listeners may access the call by dialing:

Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer

Retrieved on: 
måndag, maj 6, 2024
Research, Medical Supplies, Genetics, Health Technology, Biotechnology, Other Health, Health, Other Science, Science, School, University, International Society, North Carolina State University, Cell, Biomedical engineering, Abstract, UCL, Biomedicine, Lentivirus, Booth, Gene, Society, ISCT, Associate, Vaccine

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.

Key Points: 
  • Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market dissolvable microfluidic transduction enhancer that innovates in vitro lentivirus-mediated gene delivery techniques.
  • With an easy, walkaway workflow, the Lenti-X Transduction Sponge achieves high transduction efficiency in any cell type, enabling downstream research applications in the gene and cell therapy space.
  • “The Lenti-X Transduction Sponge will transform the viral transduction landscape with its simple yet elegant design,” said Carol Lou, President & CEO of Takara Bio USA.
  • At ISCT, attendees can engage with Takara Bio during the poster presentation (Abstract #1133) and view the Lenti-X Transduction Sponge at Booth #721.

Bitget's Blockchain4Youth Celebrates 1st Anniversary, Educated Over 6,000 Participants Worldwide

Retrieved on: 
måndag, maj 6, 2024
Education, Generation Z, Ateneo de Manila University, University College London, National Taiwan University, Blockchain, Empowerment, University, National Technological University, RMIT University, Millennials, UCL, Generation, Web 3.0, Knowledge, Cryptocurrency

Bitget envisions a more equitable future driven by the crypto revolution, and Blockchain4Youth is a testament to that vision.

Key Points: 
  • Bitget envisions a more equitable future driven by the crypto revolution, and Blockchain4Youth is a testament to that vision.
  • Over the past year, Blockchain4Youth has engaged over 6,000 participants and delivered over 54 campus lectures and workshops worldwide.
  • The courses connect young participants with the tools and knowledge to understand and utilize blockchain technology, and over 2,000 certificates were issued to participants who completed the courses and passed the test.
  • Blockchain4Youth's future plans include providing more scholarships worldwide and launching more online courses and content featuring different influencers in the field on crypto-related topics to further garner youngster's attention.

Bitget's Blockchain4Youth Celebrates 1st Anniversary, Educated Over 6,000 Participants Worldwide

Retrieved on: 
måndag, maj 6, 2024
Education, Generation Z, Ateneo de Manila University, University College London, National Taiwan University, Blockchain, Empowerment, University, National Technological University, RMIT University, Millennials, UCL, Generation, Web 3.0, Knowledge, Cryptocurrency

Bitget envisions a more equitable future driven by the crypto revolution, and Blockchain4Youth is a testament to that vision.

Key Points: 
  • Bitget envisions a more equitable future driven by the crypto revolution, and Blockchain4Youth is a testament to that vision.
  • Over the past year, Blockchain4Youth has engaged over 6,000 participants and delivered over 54 campus lectures and workshops worldwide.
  • The courses connect young participants with the tools and knowledge to understand and utilize blockchain technology, and over 2,000 certificates were issued to participants who completed the courses and passed the test.
  • Blockchain4Youth's future plans include providing more scholarships worldwide and launching more online courses and content featuring different influencers in the field on crypto-related topics to further garner youngster's attention.

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List

Retrieved on: 
fredag, maj 3, 2024
UCLA, University, Molecular genetics, University College London, Health, Kyowa Kirin, Pediatrics, Pediatric nursing, Cell, TIME, Patient, Physician, Medicine, HSC, UCL, King's College, Orchard, Therapy, Biotechnology, Pharmaceutical industry

The full list and related tributes will appear in the May 13, 2024 issue of TIME and is available online at https://time.com/collection/time100-health/ .

Key Points: 
  • The full list and related tributes will appear in the May 13, 2024 issue of TIME and is available online at https://time.com/collection/time100-health/ .
  • “I am incredibly humbled, privileged, and immensely proud to be included on this esteemed list of influential and accomplished people shaping the future of health care,” said Dr. Gaspar.
  • “Bobby is a visionary and authentic leader who inspires the very best in his colleagues and peers,” said Frank Thomas, president and chief operating officer of Orchard Therapeutics.
  • Congratulations, Bobby, and thank you for helping carry the mantel for the broader HSC gene therapy field.”

Heartland BancCorp Earns $5.1 Million, or $2.51 per Diluted Share, in the First Quarter of 2024; Declares Quarterly Cash Dividend of $0.759 per Share

Retrieved on: 
tisdag, april 16, 2024
Sale, EVP, Book, Federal Home Loan Banks, CRE, ACL, Dow Jones, Compact disc, NIM, DDA, Pressure, NPAS, Heartland Bank, UCL, FDIC, LRA, NOW, Growth, Video game

The company also announced that its board of directors declared a quarterly cash dividend of $0.759 per share.

Key Points: 
  • The company also announced that its board of directors declared a quarterly cash dividend of $0.759 per share.
  • Heartland recorded no provision for credit losses during the first quarter of 2024, compared to $750,000 for the first quarter a year ago.
  • Net loans decreased modestly during the quarter to $1.51 billion at March 31, 2024, compared to $1.53 billion three months earlier.
  • Total deposits decreased modestly during the quarter to $1.63 billion at March 31, 2024, compared to $1.64 billion three months earlier.